[go: up one dir, main page]

WO2008146085A3 - Inflammation and oxidative stress reducing composition for topical or oral administration - Google Patents

Inflammation and oxidative stress reducing composition for topical or oral administration Download PDF

Info

Publication number
WO2008146085A3
WO2008146085A3 PCT/IB2007/004618 IB2007004618W WO2008146085A3 WO 2008146085 A3 WO2008146085 A3 WO 2008146085A3 IB 2007004618 W IB2007004618 W IB 2007004618W WO 2008146085 A3 WO2008146085 A3 WO 2008146085A3
Authority
WO
WIPO (PCT)
Prior art keywords
topical
inflammation
oral administration
oxidative stress
reducing composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/004618
Other languages
French (fr)
Other versions
WO2008146085A2 (en
Inventor
Gary Viole
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from US11/770,390 external-priority patent/US20080003244A1/en
Publication of WO2008146085A2 publication Critical patent/WO2008146085A2/en
Anticipated expiration legal-status Critical
Publication of WO2008146085A3 publication Critical patent/WO2008146085A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00387—Plasters use skin protection
    • A61F2013/00391—Plasters use skin protection from irradiation, e.g. sun
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides, in one embodiment, a method for making lecithin phospholipid with lipoic or piperic acid based composition, a preparation for use as a topical skin application for treatment of infectious skin lesions such as acne, for the protection of skin cells from oxidative agents, and as anti-inflammatory treatments.
PCT/IB2007/004618 2006-06-28 2007-06-28 Inflammation and oxidative stress reducing composition for topical or oral administration Ceased WO2008146085A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US81732606P 2006-06-28 2006-06-28
US60/817,326 2006-06-28
US58086606P 2006-10-10 2006-10-10
US60/580,866 2006-10-10
US11/770,390 US20080003244A1 (en) 2006-06-28 2007-06-28 Inflammation and Oxidative Stress Reducing Compostion for Topical or Oral Administration
US11/770,390 2007-06-28

Publications (2)

Publication Number Publication Date
WO2008146085A2 WO2008146085A2 (en) 2008-12-04
WO2008146085A3 true WO2008146085A3 (en) 2009-01-29

Family

ID=39998950

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/004618 Ceased WO2008146085A2 (en) 2006-06-28 2007-06-28 Inflammation and oxidative stress reducing composition for topical or oral administration

Country Status (1)

Country Link
WO (1) WO2008146085A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102012078B1 (en) * 2017-08-02 2019-08-19 포항공과대학교 산학협력단 An anti-aging or skin regenerating composition comprising piperonylic acid as an active ingredient
US12357553B2 (en) 2017-08-02 2025-07-15 Hesed Bio Co., Ltd. Composition for treating hair loss or promoting hair growth, comprising piperonylic acid

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265345A1 (en) * 2003-06-30 2004-12-30 Perricone Nicholas V. Treatment of skin damage using acetyl carnitine and lipoic acid
WO2006015774A1 (en) * 2004-08-06 2006-02-16 Bioghurt Biogarde Gmbh & Co. Kg Physiologically acceptable composition containing alpha-lipoic acid, creatine, and a phosphatide
JP2006248904A (en) * 2005-03-08 2006-09-21 Yoshihiro Futamura ANTI-INFLAMMATORY AGENT COMPOSED OF CONJUGATE OF alpha-LIPOIC ACID AND POLYVALENT UNSATURATED FATTY ACID AND EXHIBITING FREE RADICAL SCAVENGING ACTION, FOOD FORMULATION AND COSMETIC FORMULATION COMPRISING THE SAME

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265345A1 (en) * 2003-06-30 2004-12-30 Perricone Nicholas V. Treatment of skin damage using acetyl carnitine and lipoic acid
WO2006015774A1 (en) * 2004-08-06 2006-02-16 Bioghurt Biogarde Gmbh & Co. Kg Physiologically acceptable composition containing alpha-lipoic acid, creatine, and a phosphatide
JP2006248904A (en) * 2005-03-08 2006-09-21 Yoshihiro Futamura ANTI-INFLAMMATORY AGENT COMPOSED OF CONJUGATE OF alpha-LIPOIC ACID AND POLYVALENT UNSATURATED FATTY ACID AND EXHIBITING FREE RADICAL SCAVENGING ACTION, FOOD FORMULATION AND COSMETIC FORMULATION COMPRISING THE SAME

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200724, Derwent World Patents Index; AN 2007-234399, XP002505043 *
PERRICONE ET AL: "Topical 5% alpha lipoic acid cream in the treatment of cutaneous rhytids", AESTHETIC SURGERY JOURNAL, MOSBY-YEAR BOOK, ST. LOUIS, MO, US, vol. 20, no. 3, 1 May 2000 (2000-05-01), pages 218 - 222, XP005701142, ISSN: 1090-820X *

Also Published As

Publication number Publication date
WO2008146085A2 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
WO2010070675A8 (en) Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
WO2007129270A3 (en) Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle
WO2008139122A3 (en) Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
UA88464C2 (en) Method of topical methadone administration providing systemic effect
WO2008070116A3 (en) Topical compositions for treatment of skin conditions
WO2008052044A3 (en) Use of derivatives of propofol for treating diseases associated with oxidative stress
WO2010062581A3 (en) A botanical composition for enhanced skin repair and uses thereof
WO2007092755A3 (en) Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
WO2005079143A3 (en) Topical formulations for the treatment of skin conditions
WO2008070368A3 (en) Methods and compositions for skin care
WO2009049184A9 (en) Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors
WO2008070859A3 (en) Treatment of skin conditions by dickkopf1 (dkk1)
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
WO2010121177A3 (en) Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses
WO2008042944A3 (en) Non-irritating oral care formulations
WO2008079993A3 (en) Combinations of nitric oxide and sulfide and methods of use and manufacture thereof
WO2008107092A3 (en) Use of derivatives of 4-hydroxyphenoxy acetic acid
WO2008012107A3 (en) Use of polyethylene glycol in inflammatory skin conditions and wound healing
WO2006055352A3 (en) Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
PL2465493T3 (en) Topical compositions for the prevention and treatment of irritation of mucous cells
WO2008063857A3 (en) Antioxidant dietary supplement compositions and methods for maintaining healthy skin
WO2007113531A3 (en) Topical drug delivery
WO2011143271A3 (en) Therapeutic liposomes and methods for producing and using the same
WO2014049561A3 (en) Oral composition for reinforcing skin tolerance following topical administration of a retinoid compound
WO2008146085A3 (en) Inflammation and oxidative stress reducing composition for topical or oral administration

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07874543

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07874543

Country of ref document: EP

Kind code of ref document: A2